ADDF's Drug Discovery

The Drug Discovery for Neurodegeneration conference advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies.

The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges.

The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.